[ad_1]
The manufacturer BioNTech and Pfizer delivered 63,180 doses of the Comirnaty vaccine on Monday, the pharmaceutical company Janssen Pharmaceutica delivered 4,800 doses of the Janssen vaccine on Wednesday, and AstraZeneca shipped 36,000 doses of the Vaxzevria vaccine on Friday.
Manufacturer Moderna delivered two vaccine shipments this week: 8,400 and 10,000 doses of the Spikevax vaccine.
The new shipments are stored in the warehouse of the Health Emergencies Center until the vaccines previously delivered by the manufacturers are distributed to the municipalities.
Vaccines are distributed to municipalities according to their population and vaccination rate. Municipalities are informed in advance of the expected amounts of vaccines to be administered in order to organize the vaccination process smoothly.
Residents can get vaccinated against COVID-19 by registering online at www.koronastop.lt or by calling 1808. Every Thursday all Lithuanian municipalities invite to get vaccinated without registering. Live vaccination is also carried out at the mobile vaccination points of the National Blood Center, the calendar of your tour of Lithuania can be found HERE.
1.71 million people have already been vaccinated with one or two doses of the vaccine in Lithuania. population, or 61.4 percent. society.
More detailed vaccination statistics are available on the Lithuania Statistics scoreboard.
When new shipments of vaccines arrive in Lithuania, information about them is updated on the website of the Ministry of Health.
The population vaccination plan and other relevant information about vaccines can be found on the Koronastop.lt website.
“Press release” means newsletters created and distributed by news agencies, legal entities and individuals on news about services, products, companies or institutions, etc. When deciding on the publication of content, UAB 15min takes into account the relevance of the information, the benefits for society and the public interest. The UAB “15min” is not remunerated for the publication of this content. The editorial board has the right to edit, shorten, supplement, remove links and titles in the text.
[ad_2]
